Purpose Clinical pharmacy can reduce drug-related iatrogenesis by improving the
management of adverse effects of drugs, limiting drug–drug interactions, and improving …

Background Clinical pharmacy is a discipline structured around multiple activities whose
objective is to secure patient care. Among all the specialties where it can be applied …

Introduction Immune-related adverse events are complications of immune checkpoint
inhibitors which require robust patient education and proactive follow-up to ensure timely …

Background Immune checkpoint inhibitors are associated with unique autoimmune side
effects that differ from traditional cytotoxic chemotherapy. Pharmacists may play an important …

We previously reported that successive pharmaceutical care by oncology pharmacy
specialists contributes to quality outpatient chemotherapy. However, there are a few reports …

What is known and objective Immune checkpoint inhibitors can cause immune‐related
adverse events (irAEs). Improved monitoring systems for irAEs, which include laboratory …

Immune-related adverse events (IRAEs) are becoming increasingly common as the use of
immune checkpoint inhibitors expands into more tumor types and treatment settings …

Background Immune checkpoint inhibitors (ICIs) are increasingly being used to treat
malignancies. Some patients experience immune-related adverse events (irAEs), which may …

Background: Immune checkpoint inhibitors combined chemotherapy (ICIC) are widely used
for various types of lung cancer in the past decade. However, ICIC related adverse events …

Background The use of novel immune checkpoint inhibitors (CPIs) has changed the face of
management for cutaneous malignancies since their introduction. While these agents are …